Quantitative p53 immunostaining aids in the detection of prevalent dysplasia
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Clinical Pathology"
DOI: 10.1136/jcp-2022-208721
Abstract: Aims The lack of accepted scoring criteria has precluded the use of p53 in routine practice. We evaluate the utility of automated quantitative p53 analysis in risk stratifying Barrett’s oesophagus (BE) patients using non-dysplastic BE… read more here.
Keywords: prevalent dysplasia; p53 immunostaining; p53; quantitative p53 ... See more keywords